IP Library › Assignment 067963/0094
Patent Assignment
Reel/Frame 067963/0094

Release of Security Interest

Recorded: 2024-06-27 Pages: 11
Assignor
EIGER III SA LLC
Executed: 2024-06-27
Assignee
ESPERION THERAPEUTICS, INC.
3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MICHIGAN, 48108
Covered Properties (31)
Hydroxy compounds and compositions for cholesterol management and related uses
Application: 60/441,795 →
Hydroxyl Compounds and Compositions for Cholesterol Management and Related Uses
Application: 16/142,547 →
Publication: US 2019/0263742
Fixed Dose Combinations and Formulations Comprising ETC1002 and Ezetimibe and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Application: 62/133,128 →
Fixed Dose Combinations and Formulations Comprising ETC1002 and Ezetimibe and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Application: 62/250,921 →
Fixed Dose Combinations and Formulations Comprising ETC1002 and Ezetimibe and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Application: 15/558,084 →
Publication: US 2018/0064671
Fixed Dose Combinations and Formulations Comprising ETC1002 and One or More Statins and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Application: 62/133,739 →
Fixed Dose Combinations and Formulations Comprising ETC1002 and One or More Statins and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Application: 62/277,403 →
Fixed Dose Combinations and Formulations Comprising ETC1002 and One or More Statins and Methods of Treating or Reducing Cardiovascular Disease
Application: 15/558,519 →
Publication: US 2018/0078518
Triplet Combination Formulations and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Application: 62/456,571 →
Fixed Dose Formulations
Application: 62/511,889 →
Hydroxyl Compounds and Compositions for Cholesterol Management and Related Uses
Application: 17/163,810 →
Publication: US 2021/0395175
Methods of Making Bempedoic Acid and Compositions of the Same
Application: 62/864,873 →
Triplet Combination Formulations and Methods for Treating or Reducing the Risk of Cardiovascular Disease
Application: 16/484,704 →
Publication: US 2021/0361618
Pharmaceutical Compositions Comprising Granulated Bempedoic Acid
Application: 15/859,279 →
Publication: US 2018/0338922
Sustained Release Formulations of Bempedoic Acid
Application: 62/774,083 →
Combination drug formulations for treating patients with cardiovascular disease and associated conditions
Application: 62/723,441 →
Method for Reducing Diabetes in Patients Receiving Statin Therapy
Application: 62/722,766 →
Methods for Reducing the Risk of Diabetes in Patients Being Treated for High Cholesterol-Related Illnesses
Application: 62/751,404 →
Methods for Reducing the Risk of Diabetes in Patients Being Treated for High Cholesterol-Related Illnesses
Application: 17/271,045 →
Publication: US 2021/0322376
Methods of Making Bempedoic Acid and Compositions of the Same
Application: 17/150,321 →
Publication: US 2021/0139405
Sustained Release Formulations of Bempedoic Acid
Application: 16/993,407 →
Combination Drug Formulations for Treating Patients with Cardiovascular Disease and Associated Conditions
Application: 17/271,043 →
Publication: US 2021/0322375
Hydroxyl Compounds and Compositions for Cholesterol Management and Related Uses
Patent: 7,335,799 →
Application: 10/743,470 →
Publication: US 2005/0043278
Hydroxyl Compounds and Compositions for Cholesterol Management and Related Uses
Patent: 8,497,301 →
Application: 13/470,825 →
Publication: US 2012/0225908
Hydroxyl Compounds and Compositions for Cholesterol Management and Related Uses
Patent: 9,000,041 →
Application: 13/925,818 →
Publication: US 2013/0289117
Hydroxyl Compounds and Compositions for Cholesterol Management and Related Uses
Patent: 9,624,152 →
Application: 14/674,028 →
Publication: US 2015/0344388
Hydroxyl Compounds and Compositions for Cholesterol Management and Related Uses
Application: 15/487,623 →
Publication: US 2017/0349516
Hydroxyl Compounds and Compositions for Cholesterol Management and Related Uses
Application: 16/142,547 →
Publication: US 2019/0263742
Methods of Making Bempedoic Acid and Compositions of the Same
Application: 17/150,325 →
Publication: US 2021/0139401
Fixed Dose Combinations and Formulations Comprising ETC1002 and Ezetimibe and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Application: 17/136,870 →
Publication: US 2021/0361605
Fixed Dose Combinations and Formulations Comprising ETC1002 and Ezetimibe and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Application: 15/558,084 →
Publication: US 2018/0064671
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 16, 2003
From: DASSEUX, JEAN-LOUIS HENRI; ONICIU, CARMEN DANIELA
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 014599/0889 →
Assignment of Assignor's Interest Nov 1, 2004
From: DASSEUX, JEAN-LOUIS HENRI; ONICIU, CARMEN DANIELA
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 015945/0158 →
Assignment of Assignor's Interest Mar 13, 2013
From: DASSEUX, JEAN-LOUIS HENRI; ONICIU, CARMEN DANIELA
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 029984/0863 →
Assignment of Assignor's Interest Jul 2, 2013
From: DASSEUX, JEAN-LOUIS HENRI; ONICIU, CARMEN DANIELA
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 030727/0824 →
Merger Oct 14, 2014
From: ESPERION THERAPEUTICS, INC.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 033946/0330 →
Assignment of Assignor's Interest Aug 10, 2015
From: NEWTON, ROGER SCHOFIELD; ROSENBERG, NOAH LABAN; MACDOUGALL, DIANE ELAINE
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 036288/0675 →
Assignment of Assignor's Interest Oct 5, 2015
From: NEWTON, ROGER SCHOFIELD; ROSENBERG, NOAH LABAN; MACDOUGALL, DIANE ELAINE
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 036725/0252 →
Assignment of Assignor's Interest Nov 17, 2016
From: NEWTON, ROGER SCHOFIELD; ROSENBERG, NOAH LABAN; MACDOUGALL, DIANE ELAINE
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 040363/0743 →
Assignment of Assignor's Interest Jan 12, 2017
From: NEWTON, ROGER SCHOFIELD; ROSENBERG, NOAH LABAN; MACDOUGALL, DIANE ELAINE
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 040967/0762 →
Assignment of Assignor's Interest Feb 17, 2017
From: DASSEUX, JEAN-LOUIS HENRI; ONICIU, CARMEN DANIELA
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 041284/0668 →
Merger Feb 17, 2017
From: ESPERION THERAPEUTICS, INC.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 041284/0685 →
Assignment of Assignor's Interest Apr 12, 2017
From: LALWANI, NARENDRA; MACDOUGALL, DIANE
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 041988/0091 →
Merger Aug 7, 2017
From: ESPERION THERAPEUTICS, INC.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 043218/0548 →
Assignment of Assignor's Interest Aug 7, 2017
From: DASSEUX, JEAN-LOUIS HENRI; ONICIU, CARMEN DANIELA
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 043219/0078 →
Assignment of Assignor's Interest Nov 2, 2017
From: PILGAONKAR, PRATIBHA S; GANDHI, ANILKUMAR S.
To: RUBICON RESEARCH PVT. LTD.
Reel/Frame 044012/0663 →
Assignment of Assignor's Interest Nov 2, 2017
From: ABDELNASSER, MOHAMED
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 044012/0660 →
Assignment of Assignor's Interest Nov 6, 2017
From: RUBICON RESEARCH PVT. LTD.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 044040/0235 →
Assignment of Assignor's Interest Mar 6, 2018
From: ABDELNASSER, MOHAMED
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 045121/0185 →
Assignment of Assignor's Interest Mar 6, 2018
From: PILGAONKAR, PRATIBHA S.; GANDHI, ANILKUMAR S.
To: RUBICON RESEARCH PVT. LTD.
Reel/Frame 045121/0195 →
Assignment of Assignor's Interest May 23, 2018
From: RUBICON RESEARCH PVT. LTD.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 045884/0773 →
Assignment of Assignor's Interest May 23, 2018
From: RUBICON RESEARCH PVT. LTD.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 045884/0750 →
Assignment of Assignor's Interest Feb 19, 2019
From: LALWANI, NARENDRA DHANRAJ; ABDELNASSER, MOHAMED; PINKOSKY, STEPHEN LAWRENCE; CRAMER, CLAY THOMAS
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 048374/0449 →
Security Interest Jun 28, 2019
From: ESPERION THERAPEUTICS, INC.
To: EIGER III SA LLC, AS PURCHASER AGENT
Reel/Frame 049623/0629 →
Assignment of Assignor's Interest Oct 6, 2019
From: LALWANI, NARENDRA; MACDOUGALL, DIANE ELAINE
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 050634/0057 →
Assignment of Assignor's Interest Oct 15, 2019
From: LALWANI, NARENDRA DHANRAJ
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 050723/0246 →